ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Short Interest Update

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 14,273 shares, a decline of 39.3% from the June 15th total of 23,522 shares. Based on an average daily volume of 69,188 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the company’s shares are sold short.

ALPS Group Inc Ordinary Share Stock Performance

Shares of ALPS traded up $0.06 during trading on Friday, reaching $0.50. The company’s stock had a trading volume of 196,478 shares, compared to its average volume of 263,170. ALPS Group Inc Ordinary Share has a twelve month low of $0.45 and a twelve month high of $15.00. The company has a market cap of $83.20 million, a P/E ratio of 1.52 and a beta of -0.12. The business’s fifty day moving average price is $0.68.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research report on Monday, July 6th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, ALPS Group Inc Ordinary Share currently has a consensus rating of “Sell”.

About ALPS Group Inc Ordinary Share

ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.